Cas:76952-35-7 3-Amino-N-hydroxy-pyrazinecarboximidamide manufacturer & supplier

Chemical Name:3-Amino-N-hydroxy-pyrazinecarboximidamide

CAS.NO:76952-35-7

Synonyms:2-Aminopyrazin-3-carbonitril;3-Amino-N-hydroxy-pyrazinecarboximidamide;2-aminopyrazine-3-carboxamide oxime;3-Amino-N-hydroxy-2-pyrazinecarboximidamide;amino-2 cyano-3 pyrazine;2-AMINO-3-CYANOPYRAZINE;3-aminopyrazinecarbonitrile;2-aminopyrazine-3-carboxamidoxime;2-Pyrazinecarboximidamide, 3-amino-N-hydroxy-;3-Amino-pyrazin-2-carbonitril;3-amino-pyrazine-2-carbonitrile;3-amino-2-pyrazinecarbonitrile

Molecular Formula:C₅H₇N₅O

Molecular Weight:153.142

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:386.7±52.0 °C at 760 mmHg

Density:1.7±0.1 g/cm3

Index of Refraction:1.762

PSA:107.91000

Exact Mass:153.065063

LogP:0.46

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Aminopyrazin-3-carbonitril chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-amino-2-pyrazinecarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-aminopyrazine-3-carboxamidoxime Use and application,2-AMINO-3-CYANOPYRAZINE technical grade,usp/ep/jp grade.

Related News: Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. 3-Amino-N-hydroxy-pyrazinecarboximidamide manufacturer Among 30,000 volunteers — all of them from either the United States or Mexico — vaccinated people were completely protected against severe and even moderate cases of illness. 3-Amino-N-hydroxy-pyrazinecarboximidamide supplier Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 3-Amino-N-hydroxy-pyrazinecarboximidamide vendor Among 30,000 volunteers — all of them from either the United States or Mexico — vaccinated people were completely protected against severe and even moderate cases of illness. 3-Amino-N-hydroxy-pyrazinecarboximidamide factory Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development.